Inventor · disambiguated record
Amal Ting
Also filed as: TING AMAL
5 granted patents·7 pending applications·20 citations·filing 2012–2016
76Inventor score
Top patents by PatentIndex Score
12 records- 0188US8765963B2Fatty acid niacin conjugates and their usesMILNE JILL C·Filed 2012·Granted Jul 1, 2014·6 cites·40 claims
- 0286US9738610B2Indazole derivatives and uses thereofWHITEHEAD INST BIOMEDICAL RES·Filed 2013·Granted Aug 22, 2017·7 cites·19 claims
- 0376US9150504B2Fatty acid guanidine and salicylate guanidine derivatives and their usesMILNE JILL C·Filed 2012·Granted Oct 6, 2015·3 cites·18 claims
- 0475US9029548B2Fatty acid lenalidomide derivatives and their usesMILNE JILL C·Filed 2012·Granted May 12, 2015·3 cites·6 claims
- 0567US9084826B2Fatty acid conjugates of statin and FXR agonists; compositions and method of usesCATABASIS PHARMACEUTICALS INC·Filed 2013·Granted Jul 21, 2015·1 cites·15 claims
- 0654US2013244966A1Fatty acid antiviral conjugates and their usesCATABASIS PHARMACEUTICALS INC·Filed 2012·Application pending·0 cites
- 0749US2016129122A1Fatty acid antiviral conjugates and their usesCATABASIS PHARMACEUTICALS INC·Filed 2016·Application pending·0 cites
- 0842US2014288025A1Fatty acid antiviral conjugates and their usesCATABASIS PHARMACEUTICALS INC·Filed 2014·Application pending·0 cites
- 0941US2013059801A1Fatty acid amides, compositions and methods of useMILNE JILL C·Filed 2012·Application pending·0 cites
- 1040US2012252810A1Fatty acid non-flushing niacin derivatives and their usesVU CHI B·Filed 2012·Application pending·0 cites
- 1138US2017073305A1Fatty acid amides, compositions and methods of useCATABASIS PHARMACEUTICALS INC·Filed 2016·Application pending·0 cites
- 1238US2016015819A1Fatty acid conjugates of statin and fxr agonists: compositions and methods of useCATABASIS PHARMACEUTICALS INC·Filed 2015·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Amal Ting files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →